[LGND] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
09-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 39.09%
YoY- 1,208.39%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 41,848 24,808 45,663 33,375 21,619 17,701 14,973 18.66%
PBT -11,612 -19,871 79,226 12,071 804 7,284 901 -
Tax -4,911 -4,620 11,864 3,645 160 -217,255 124 -
NP -6,701 -15,251 67,362 8,426 644 199,165 1,280 -
Tax Rate - - -14.97% -30.20% -19.90% 2,982.63% -13.76% -
Total Cost 48,549 40,059 -21,699 24,949 20,975 -181,464 13,693 23.46%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -16.01 -61.48 147.52 25.25 2.98 1,125.16 8.55 -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.42 -0.81 3.19 0.40 0.03 10.01 0.06 -
EPS Diluted -0.42 -0.81 2.80 0.36 0.03 9.28 0.06 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.